Press Releases

MacDougall Creative 8/10/20 MacDougall Creative 8/10/20

OncoNano Awarded $9.97 Million Grant from Cancer Prevention and Research Institute of Texas

MacDougall Creative 6/26/20 MacDougall Creative 6/26/20

OncoNano Announces Publication of ONM-100 Phase 1 Data in Nature Communications

MacDougall Creative 11/4/19 MacDougall Creative 11/4/19

OncoNano Announces Presentations at the 2019 SITC Annual Meeting

MacDougall Creative 9/10/19 MacDougall Creative 9/10/19

ONM-100 to be Featured in Presentation at World Molecular Imaging Congress 2019

MacDougall Creative 8/27/19 MacDougall Creative 8/27/19

OncoNano Awarded $15.4 Million Grant from Cancer Prevention and Research Institute of Texas

MacDougall Creative 7/9/19 MacDougall Creative 7/9/19

OncoNano Closes Additional $23.7 Million in Second Tranche of Series A Financing, Bringing Total Series A Raise to $35.4 Million

MacDougall Creative 5/23/19 MacDougall Creative 5/23/19

OncoNano to Present Poster on First-in-Human Study of pH-Activated Platform for Detection of Solid Tumors During Surgery at 2019 ASCO Annual Meeting

MacDougall Creative 1/3/19 MacDougall Creative 1/3/19

OncoNano Receives Authorization to Proceed from FDA for IND Application and Fast Track Designation for ONM-100, Intraoperative Imaging Agent to Detect Tumors and Metastatic Lymph Nodes

MacDougall Creative 12/4/18 MacDougall Creative 12/4/18

OncoNano Announces Completion of Phase 1a Study and Expands into Phase 1b for Intraoperative Imaging Agent to Detect Tumors and Metastatic Lymph Nodes That Often Go Undetected During Surgery

MacDougall Creative 7/10/18 MacDougall Creative 7/10/18

OncoNanoAnnounces Dosing of Patientsin Phase 1 Clinical Trial with ONM-100, an Intraoperative Imaging Agent that Targets Tumor Acidosisforthe Detection of Solid Tumors

MacDougall Creative 5/17/18 MacDougall Creative 5/17/18

OncoNano Announces $11.7 Million Series A Financing to Support Development of pH-activated Compound Platform for Disease Detection and Treatment